Spontaneous Regression of Meningiomas: Literature Review and Case Report

Ali Özen; Abuzer Güngör; Uğur Türe

doi:10.1055/s-0045-1812073

Asian Journal of Neurosurgery, Inhaltsverzeichnis

CC BY-NC-ND 4.0 · Asian J Neurosurg
DOI: 10.1055/s-0045-1812073

Case Report

Spontaneous Regression of Meningiomas: Literature Review and Case Report

Authors

Ali Özen

¹Department of Neurosurgery, Yeditepe University School of Medicine, İstanbul, Türkiye
Abuzer Güngör

¹Department of Neurosurgery, Yeditepe University School of Medicine, İstanbul, Türkiye

²Department of Neurosurgery, İstinye University School of Medicine, İstanbul, Türkiye
Uğur Türe

¹Department of Neurosurgery, Yeditepe University School of Medicine, İstanbul, Türkiye

Abstract

Meningiomas are one of the most common primary tumors of the central nervous system, and surgical excision is the gold standard treatment for symptomatic patients. But there is no common algorithm for treatment in asymptomatic patients. Many studies have investigated the natural course of incidental meningiomas. Spontaneous regression refers to the shrinkage of a tumor without any intervention or treatment. Current data on spontaneous regression of meningiomas consists only of case reports. In this article, we present the case of a patient with an incidental meningioma that spontaneously regressed during follow-up and include a review of the literature.

Keywords

asymptomatic meningioma - incidental meningioma - regression - shrinkage - spontaneous

Volltext

Referenzen

References
1 Nakamura M, Roser F, Michel J, Jacobs C, Samii M. The natural history of incidental meningiomas. Neurosurgery 2003; 53 (01) 62-70 , discussion 70–71
2 Nakasu S, Hirano A, Shimura T, Llena JF. Incidental meningiomas in autopsy study. Surg Neurol 1987; 27 (04) 319-322
3 Kim KH, Kang SJ, Choi JW. et al. Clinical and radiological outcomes of proactive Gamma Knife surgery for asymptomatic meningiomas compared with the natural course without intervention. J Neurosurg 2018; 130 (05) 1740-1749
4 Yano S, Kuratsu J. Kumamoto Brain Tumor Research Group. Indications for surgery in patients with asymptomatic meningiomas based on an extensive experience. J Neurosurg 2006; 105 (04) 538-543
5 Mohammad MH, Chavredakis E, Zakaria R, Brodbelt A, Jenkinson MD. A national survey of the management of patients with incidental meningioma in the United Kingdom. Br J Neurosurg 2017; 31 (04) 459-463
6 Yoneoka Y, Fujii Y, Tanaka R. Growth of incidental meningiomas. Acta Neurochir (Wien) 2000; 142 (05) 507-511
7 Niiro M, Yatsushiro K, Nakamura K, Kawahara Y, Kuratsu J. Natural history of elderly patients with asymptomatic meningiomas. J Neurol Neurosurg Psychiatry 2000; 68 (01) 25-28
8 Firsching RP, Fischer A, Peters R, Thun F, Klug N. Growth rate of incidental meningiomas. J Neurosurg 1990; 73 (04) 545-547
9 Kuratsu J, Kochi M, Ushio Y. Incidence and clinical features of asymptomatic meningiomas. J Neurosurg 2000; 92 (05) 766-770
10 Oya S, Kim SH, Sade B, Lee JH. The natural history of intracranial meningiomas. J Neurosurg 2011; 114 (05) 1250-1256
11 Islim AI, Millward CP, Mills SJ. et al. The management of incidental meningioma: An unresolved clinical conundrum. Neurooncol Adv 2023; 5 (Suppl. 01) i26-i34
12 Cole WH, Everson TC. Spontaneous regression of cancer: preliminary report. Ann Surg 1956; 144 (03) 366-383
13 Hoption Cann SA, van Netten JP, van Netten C, Glover DW. Spontaneous regression: a hidden treasure buried in time. Med Hypotheses 2002; 58 (02) 115-119
14 Gonçalves AMG, Page P, Domigo V, Méder JF, Oppenheim C. Abrupt regression of a meningioma after discontinuation of cyproterone treatment. AJNR Am J Neuroradiol 2010; 31 (08) 1504-1505
15 de Almeida JPC, Petteys RJ, Sciubba DM, Gallia GL, Brem H. Regression of intracranial meningioma following intratumoral hemorrhage. J Clin Neurosci 2009; 16 (09) 1246-1249
16 Shahin MN, Bowden SG, Yaghi NK. et al. Regression of multiple meningiomas after discontinuation of chronic hormone therapy: a case report. J Neurol Surg Rep 2021; 82 (04) e38-e42
17 Hoegestoel EA, Berg-Johnsen J. Regression of intracranial meningioma during treatment with α1-adrenoceptor blocker. J Neurol Surg Rep 2016; 77 (01) e62-e65
18 Yilmaz A, Kizilay Z, Sair A, Avcil M, Ozkul A. Spontaneous regression of an incidental spinal meningioma. Open Access Maced J Med Sci 2016; 4 (01) 128-130
19 Kerschbaumer J, Freyschlag CF, Stockhammer G. et al. Hormone-dependent shrinkage of a sphenoid wing meningioma after pregnancy: case report. J Neurosurg 2016; 124 (01) 137-140
20 Kalamarides M, Peyre M. Dramatic shrinkage with reduced vascularization of large meningiomas after cessation of progestin treatment. World Neurosurg 2017; 101: 814.e7-814.e10
21 Galloway L, Vakili N, Spears J. Spontaneous regression of a parafalcine meningioma in a multiple sclerosis patient being treated with interferon beta-1a. Acta Neurochir (Wien) 2017; 159 (03) 469-471
22 Shimizu J, Matsumoto M, Yamazaki E, Yasue M. Spontaneous regression of an asymptomatic meningioma associated with discontinuation of progesterone agonist administration. Neurol Med Chir (Tokyo) 2008; 48 (05) 227-230
23 Passeri T, Champagne PO, Bernat AL. et al. Spontaneous regression of meningiomas after interruption of nomegestrol acetate: a series of three patients. Acta Neurochir (Wien) 2019; 161 (04) 761-765
24 Hirota K, Fujita T, Akagawa H, Onda H, Kasuya H. Spontaneous regression together with increased calcification of incidental meningioma. Surg Neurol Int 2014; 5: 73
25 Watanabe S, Tsuchiya D, Kinjo T. Spontaneous regression of meningiomas: a report of three cases. Jpn J Neurosurg (Tokyo) 2012; 21: 250-254
26 Takada M, Yanaka K, Nakamura K, Akimoto K, Takeda H, Ishikawa E. Spontaneous regression of a posterior fossa meningioma: a case report. Surg Neurol Int 2022; 13: 334
27 Kumaria A, Ingale HA, Macarthur DC. Spontaneous regression of a large skull base meningioma: case report. Br J Neurosurg 2020; 34 (02) 205-206
28 Pozzati E, Zucchelli M, Schiavina M, Contini P, Foschini MP. Rapid growth and regression of intracranial meningiomas in lymphangioleiomyomatosis: case report. Surg Neurol 2007; 68 (06) 671-674
29 Kim BS, Jung T-Y, Moon K-S, Kim I-Y, Jung S. Meningioma with partial and spontaneous regression of peritumoral edema on long-term follow up. Brain Tumor Res Treat 2022; 10 (04) 275-278
30 Behbahani M, Skeie GO, Eide GE, Hausken A, Lund-Johansen M, Skeie BS. A prospective study of the natural history of incidental meningioma-Hold your horses!. Neurooncol Pract 2019; 6 (06) 438-450
31 Nakasu S, Nakasu Y. Natural history of meningiomas: review with meta-analyses. Neurol Med Chir (Tokyo) 2020; 60 (03) 109-120
32 Sughrue ME, Rutkowski MJ, Aranda D, Barani IJ, McDermott MW, Parsa AT. Treatment decision making based on the published natural history and growth rate of small meningiomas. J Neurosurg 2010; 113 (05) 1036-1042
33 Hashimoto N, Rabo CS, Okita Y. et al. Slower growth of skull base meningiomas compared with non-skull base meningiomas based on volumetric and biological studies. J Neurosurg 2012; 116 (03) 574-580
34 Arnautović KI, Al-Mefty O, Husain M. Ventral foramen magnum meninigiomas. J Neurosurg 2000; 92 (1, Suppl): 71-80
35 Kinjo T, al-Mefty O, Ciric I. Diaphragma sellae meningiomas. Neurosurgery 1995; 36 (06) 1082-1092
36 Heth JA, Al-Mefty O. Cavernous sinus meningiomas. Neurosurg Focus 2003; 14 (06) e3
37 Al-Mefty O. Clinoidal meningiomas. J Neurosurg 1990; 73 (06) 840-849
38 Harrison MJ, al-Mefty O. Tentorial meningiomas. Clin Neurosurg 1997; 44: 451-466
39 Aum D, Rassi MS, Al-Mefty O. Petroclival meningiomas and the petrosal approach. Handb Clin Neurol 2020; 170: 133-141
40 Yaşargil MG. Meningiomas. In: Yaşargil MG. ed. Microneurosurgery. Vol. IVB-Microneurosurgery of CNS Tumors. New York: Thieme Medical Publishers, Inc; 1996: 134-165
41 Cushing H. 1869–1939, Eisenhardt L 1891–1967, Schlesinger EB donor. Meningiomas, their classification, regional behaviour, life history, and surgical end results [Internet]. Springfield, III.: Thomas, 1938; 1938. Accessed August 10, 2024 at: https://www.ncbi.nlm.nih.gov/nlmcatalog/154858
42 Rubin G, Herscovici Z, Laviv Y, Jackson S, Rappaport ZH. Outcome of untreated meningiomas. Isr Med Assoc J 2011; 13 (03) 157-160
43 Mehdorn HM. Intracranial meningiomas: a 30-year experience and literature review. Adv Tech Stand Neurosurg 2016; (43) 139-184
44 Glenn CA, Tullos HJ, Sughrue ME. Natural history of intracranial meningiomas. In: Handbook of Clinical Neurology. Vol 169. Elsevier; 2020: 205-227
45 Herscovici Z, Rappaport Z, Sulkes J, Danaila L, Rubin G. Natural history of conservatively treated meningiomas. Neurology 2004; 63 (06) 1133-1134
46 Van Havenbergh T, Carvalho G, Tatagiba M, Plets C, Samii M. Natural history of petroclival meningiomas. Neurosurgery 2003; 52 (01) 55-62 , discussion 62–64
47 Niiro M, Yatsushiro K, Nakamura K, Kawahara Y, Kuratsu J. Natural history of elderly patients with asymptomatic meningiomas. J Neurol Neurosurg Psychiatry 2000; 68 (01) 25-28
48 Yasumoto Y, Ito M. Spontaneous regression of a growing vestibular schwannoma. Neurol Med Chir (Tokyo) 2006; 46 (12) 601-604
49 Luetje CM, Whittaker CK, Davidson KC, Vergara GG. Spontaneous acoustic tumor involution: a case report. Otolaryngol Head Neck Surg 1988; 98 (01) 95-97
50 Gil M, Oliva B, Timoner J, Maciá MA, Bryant V, de Abajo FJ. Risk of meningioma among users of high doses of cyproterone acetate as compared with the general population: evidence from a population-based cohort study. Br J Clin Pharmacol 2011; 72 (06) 965-968
51 Olson JJ, Beck DW, Schlechte J, Loh PM. Hormonal manipulation of meningiomas in vitro. J Neurosurg 1986; 65 (01) 99-107